ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community
(Turk J Gastroenterol 2007; 18: 14-19)
Review
What is the place of empirical proton pump inhibitor testing in the diagnosis of gastroesophageal reflux disease? (Description, duration, and dosage)
(Turk J Gastroenterol 2017; 28: 12-15)
DOI: 10.5152/tjg.2017.05
Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 16-21)
DOI: 10.5152/tjg.2017.06
Which diseases are risk factors for developing gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 44-47)
DOI: 10.5152/tjg.2017.12
Original Article
The role of interleukin-1 gene polymorphisms and Helicobacter pylori in gastroesophageal reflux disease
(Turk J Gastroenterol 2014; 25: 81-85)
DOI: 10.5152/tjg.2014.6512
Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease
(Turk J Gastroenterol 2016; 27: 408-414)
DOI: 10.5152/tjg.2016.15514
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2017 Turkish Society of Gastroenterology | Latest Update: 30.11.2017